Mackay Shields LLC’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-35,640
Closed -$1.25M 571
2022
Q1
$1.25M Sell
35,640
-1,509
-4% -$51.6K 0.01% 615
2021
Q4
$1.13M Sell
37,149
-787
-2% -$25.6K 0.01% 619
2021
Q3
$1.24M Sell
37,936
-1,909
-5% -$61.1K 0.01% 595
2021
Q2
$1.21M Buy
+39,845
New +$1.31M 0.01% 597

Other funds holding OGN

Mackay Shields LLC's OGN Position: Q2 2022 in Review

Mackay Shields LLC sold out of Organon & Co (OGN) in Q2 2022, closing a stake of 35,640 shares — an estimated $1.25M sold.

Mackay Shields LLC first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $1.25M in Q1 2022. 853 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

  • Mackay Shields LLC reported no remaining Organon & Co position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 35,640 Organon & Co shares in Q2 2022, an estimated $1.25M.
  • Mackay Shields LLC first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
  • Mackay Shields LLC's Organon & Co position peaked at $1.25M in Q1 2022.
  • 853 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.